Track topics on Twitter Track topics that are important to you
The recommended dose of Keytruda for the adjuvant treatment of adult patients with melanoma is 200 mg administered as an intravenous infusion over 30 minutes every three weeks
The post Merck gets FDA nod for Keytruda as adjuvant treatment for melanoma appeared first on Pharmaceutical Business review.
Original Article: Merck gets FDA nod for Keytruda as adjuvant treatment for melanomaNEXT ARTICLE
Melanoma is a highly malignant tumor of melanin-forming cells (melanocytes) There are most commonly found in the skin (resulting from sunlight exposure), but also in the eyes and mucous membranes. Metastasis to other regions of the body is also common....